Ecenofloxacin

DB19793ExperimentalSmall molecule

Ecenofloxacin is a small molecule drug. The usage of the INN stem '-oxacin' in the name indicates that Ecenofloxacin is a nalidixic acid derivative antibacterial. Ecenofloxacin has a monoisotopic molecular...

Formula / weight: C₁₉H₂₁FN₄O₃ · 372.4 g/mol (avg)
Code names: CFC-222

Resolves to

Compound

UNII3613ZY362LCAS162301-05-5ChEMBLCHEMBL2107637ChEBI752765PubChem178066

Structure

InChIKeyWNVIWAUAXKEKKF-PJFSTRORSA-NSMILES[H][C@@]12CN(C[C@]1(C)C[C@@H]2N)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=N1)C(O)=O

Targets

P20831gyrAP0A0K8gyrB

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ecenofloxacin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account